GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » Capex-to-Revenue

CLPBY (Coloplast AS) Capex-to-Revenue : 0.06 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Coloplast AS's Capital Expenditure for the three months ended in Sep. 2024 was $-66.09 Mil. Its Revenue for the three months ended in Sep. 2024 was $1,034.98 Mil.

Hence, Coloplast AS's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.06.


Coloplast AS Capex-to-Revenue Historical Data

The historical data trend for Coloplast AS's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Capex-to-Revenue Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.10 0.05 0.05 0.05

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.04 0.04 0.05 0.06

Competitive Comparison of Coloplast AS's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Coloplast AS's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Capex-to-Revenue falls into.



Coloplast AS Capex-to-Revenue Calculation

Coloplast AS's Capex-to-Revenue for the fiscal year that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-200.357) / 4023.519
=0.05

Coloplast AS's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-66.091) / 1034.981
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS  (OTCPK:CLPBY) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Coloplast AS Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Coloplast A/S to Acquire Atos Medical Call Transcript

By GuruFocus Research 02-13-2024

Q2 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S's Dividend Analysis

By GuruFocus Research 05-17-2024

Coloplast A/S Virtual ESG Event Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024